|
?:authorAffiliation
|
-
[\'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.\', \'Institute of Global Health, University of Siena, Siena, Italy.\', \'The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil.\', \'Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.\', \'Escola Bahiana de Medicina e Saúde Pública, Brazil and ID\'OR, Salvador, Brazil.\', \'Hospital São Rafael, Salvador, Brazil.\', \'Universidade Federal do Rio Grande do Norte - UFRN, Natal, Brazil.\', \'Hospital Quinta D\'Or, Rio de Janeiro, Brazil.\', \'Instituto D\'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil.\', \'Universidade Unigranrio, Rio de Janeiro, Brazil.\', \'Clinical Research Unit, Department of Clinical Medicine, Universidade Federal de Santa Maria, Santa Maria, Brazil.\', \'Infectious Diseases Service, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.\', \'Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.\', \'Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'Oxford University Hospitals NHS Foundation Trust, Oxford, UK.\', \'Oxford Viral Sequencing Group, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. merryn.voysey@paediatrics.ox.ac.uk.\', \'Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.pollard@paediatrics.ox.ac.uk.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}